PPARA and neoplasm: In fact, we found that deletion of PPARα in the tumor cell itself potentiated the tumor suppressing effect of PPARα-deficiency in the host tissue (Figure 1G and H), in agreement with the earlier reports of the requirement for PPARα in PPARα agonist induced liver tumors [9].